Why do you change the injection site?
· 3 min
Years of injections into the same area quietly change how fast the insulin given there reaches the blood. A small bump may show on the surface, and sometimes no trace shows at all; what changes is the tissue under the skin. That is the real reason the injection site gets changed.
Insulin isn’t only a molecule that touches blood sugar. It also carries a growth call to fat cells. If the same small area keeps getting that call for years, its fat tissue both grows in volume and multiplies in number. What appears isn’t a simple “swelling.” One study points to insulin’s fat-building action, not the needle’s injury, as the bump’s main source. Field surveys also name needle tip reuse alongside the hardening; not a mechanism seen there, but a companion tangled up with insisting on the same area.
The changed tissue isn’t like healthy skin in its underlying capillary network. Passage into the blood from there both slows noticeably and differs day to day. The same injection that works as expected one day falls well short the next. This unsteadiness stands out as a quiet source of unexplained ups and downs in readings. Guidelines therefore call regular site checks important.
Reading this as laziness or clumsiness would be wrong from start to finish. Hardening can appear even in people with sound technique; the real decider is how often the same area gets loaded. The suitable surface under the skin is far wider than assumed; most people keep circling a small piece of it. In people who spread the load widely, studies find that share much lower.
| Under healthy skin | Hardened tissue |
|---|---|
| Capillary network dense, blood flow steady | Capillary support weakens, flow turns irregular |
| Absorption follows a predictable line | Absorption both slows and swings day to day |
| Same amount gives a similar result | Same amount can produce different results |
| Needle prick feels normal | Feels easier because sensitivity has dropped |
There’s also a loop that feeds itself. Since the hardened area’s sensitivity has dropped, the needle hurts less there; that easier spot gets picked again without notice. So the tissue keeps growing and absorption grows even less reliable. What starts the loop isn’t pain, it’s habit.
Why the same spot gets picked every time hides in daily life. With the light off, the hand finds the most familiar place by itself. Where clothing slides up most easily becomes the only option over time. When hurry cuts in, the nearest surface comes forward; the far sides of the arm or leg never get a turn. All three leave the same small area under the same load for years.
Lipohypertrophy isn’t rare; it shows up in about half of insulin users. Small, flat bumps escape the eye easily. Feeling by hand at an exam catches a significant share of these areas; ultrasound can show the change even with no surface trace. When an area goes unloaded for a while, the tissue can slowly pull back. But that return isn’t quick, and it lags even more with long-settled bumps. Noticing early is valuable for that reason. Your care team can see where things stand by feeling these areas at a checkup.
Sources
- Tian T, Aaron RE, Huang J, et al. Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society. Journal of Diabetes Science and Technology. 2023;17(6):1711-1721.
- Barola A, Tiwari P, Bhansali A, Grover S, Dayal D. Insulin-Related Lipohypertrophy: Lipogenic Action or Tissue Trauma? Frontiers in Endocrinology. 2018;9:638.
- Blanco M, Hernandez MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes and Metabolism. 2013;39(5):445-453.
- American Diabetes Association Professional Practice Committee. 7. Diabetes technology: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S150-S165. doi:10.2337/dc26-S007. PMCID: PMC12690173.